These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31622993)
1. Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER). Spirk D; Sebastian T; Banyai M; Beer JH; Mazzolai L; Baldi T; Aujesky D; Hayoz D; Engelberger RP; Kaeslin T; Korte W; Escher R; Husmann M; Mollet A; Szucs TD; Kucher N Semin Thromb Hemost; 2019 Nov; 45(8):851-858. PubMed ID: 31622993 [TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER). Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301 [TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER). Spirk D; Sebastian T; Barco S; Banyai M; Beer JH; Mazzolai L; Baldi T; Aujesky D; Hayoz D; Engelberger RP; Kaeslin T; Korte W; Escher R; Husmann M; Blondon M; Kucher N Thromb Haemost; 2021 May; 121(5):641-649. PubMed ID: 33202448 [TBL] [Abstract][Full Text] [Related]
4. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease. Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK; JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399 [TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER). Spirk D; Aujesky D; Stuck AK; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Kucher N Semin Thromb Hemost; 2016 Sep; 42(6):642-9. PubMed ID: 27272967 [TBL] [Abstract][Full Text] [Related]
6. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention. Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466 [TBL] [Abstract][Full Text] [Related]
7. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER). Wenger N; Sebastian T; Beer JH; Mazzolai L; Aujesky D; Hayoz D; Engelberger RP; Korte W; Voci D; Kucher N; Barco S; Spirk D Thromb Res; 2022 Dec; 220():65-71. PubMed ID: 36272334 [TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment. Messi M; Beneyto Afonso C; Stalder O; Méan M; Righini M; Rodondi N; Aujesky D Thromb Res; 2022 Oct; 218():64-71. PubMed ID: 35994838 [TBL] [Abstract][Full Text] [Related]
9. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial. Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA; JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719 [TBL] [Abstract][Full Text] [Related]
10. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer. Kirkilesis GI; Kakkos SK; Tsolakis IA Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186 [TBL] [Abstract][Full Text] [Related]
11. Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II. Spirk D; Ugi J; Korte W; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Aujesky D; Baumgartner I; Kucher N Thromb Haemost; 2011 Jun; 105(6):962-7. PubMed ID: 21475778 [TBL] [Abstract][Full Text] [Related]
12. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism. Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194 [TBL] [Abstract][Full Text] [Related]
13. Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry. Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T; J Thromb Thrombolysis; 2019 Apr; 47(3):444-453. PubMed ID: 30673941 [TBL] [Abstract][Full Text] [Related]
14. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review. Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174 [TBL] [Abstract][Full Text] [Related]
15. Enoxaparin for Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency. Sigüenza P; López-Núñez JJ; Falgá C; Gómez-Cuervo C; Riera-Mestre A; Gil-Díaz A; Verhamme P; Montenegro AC; Barbagelata C; Imbalzano E; Monreal M; Thromb Haemost; 2024 Apr; 124(4):363-373. PubMed ID: 37832588 [TBL] [Abstract][Full Text] [Related]
16. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry. Yamashita Y; Yoshikawa Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T; Int J Cardiol; 2019 Oct; 292():198-204. PubMed ID: 31239211 [TBL] [Abstract][Full Text] [Related]
17. Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry. Bikdeli B; Jiménez D; Garcia-Tsao G; Barba R; Font C; Díaz-Pedroche MDC; Mazzolai L; Little DHW; Tufano A; Tafur AJ; Siegal D; Lip GYH; Monreal M; Semin Thromb Hemost; 2019 Nov; 45(8):793-801. PubMed ID: 31614388 [TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry. Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T; Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959 [TBL] [Abstract][Full Text] [Related]
20. Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial. Becattini C; Bauersachs R; Maraziti G; Bertoletti L; Cohen A; Connors JM; Manfellotto D; Sanchez A; Brenner B; Agnelli G Haematologica; 2022 Jul; 107(7):1567-1576. PubMed ID: 34382385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]